A study to evaluate the relationship between Tie2-expressing monocytes/TEMs as a biomarker and response to sorafenib treatment in patients with advanced hepatocellular carcinoma
Latest Information Update: 11 Mar 2016
At a glance
- Drugs Sorafenib (Primary)
- Indications Liver cancer
- Focus Biomarker; Pharmacodynamics; Therapeutic Use
Most Recent Events
- 11 Mar 2016 New trial record